ROSENBERG, TEXAS, May 30, 2014 – Nexgen Pharma, Inc. (Nexgen), a specialty pharmaceutical company that provides development and manufacturing services for Rx, OTC drugs as well as custom dietary supplement formulations, announced today that it has acquired the manufacturing operations of Elge, Inc. in a transaction that will broaden its product lines and its geographic footprint.
Elge, Inc., based in Rosenberg, TX, is a leading manufacturer of high-quality Rx and OTC drugs, with specialized processing capabilities for liquid formulations.
Steve Brown, CEO of Nexgen, said, "Elge is a highly respected pharmaceuticals manufacturer that is well recognized in our industry and for its value added processing capabilities, as well as for its technical expertise, providing a strong platform for us to pursue new market opportunities. We are impressed with the company's operations and look forward to working with the management team to build on their strong customer relationships."
Larry Gremminger, President of Elge, said, "The combination of Nexgen and Elge is a strong market fit that creates an organization better positioned to provide superior quality products that improve health."
Additional information is available at www.nexgenpharma.com .
Contact: Gary Korngold, President, Nexgen Pharma, Inc.